# Rockwell Medical (RMTI) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/RMTI
## Company Profile
- Ticker: RMTI
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 8.06 USD
- Market cap: 27988389.0209 USD
- Last updated: 2026-09-08
## Business Overview
Rockwell Medical is a specialty pharmaceutical and device company focused on iron management and dialysis care. Its business is centered on products used in renal treatment settings.
## Why The Stock Is Moving

As of Sep 8, 2026, RMTI closed up 0.94% at $8.06. No new same-company headline was identified in the current news window.

## Geographic Base

Headquartered in the United States and listed on NASDAQ, Rockwell sits in specialty biopharma and renal care.

## Business Model

The company depends on product adoption, dialysis-market access, and the economics of renal treatment workflows.

## Landscape Position

Rockwell is a niche renal-care company whose stock moves on commercial execution and product use.

## Future Catalysts

- Rockwell Medical’s catalysts are dialysis-iron demand, manufacturing execution, and continued commercialization of Triferic and related products. Investors will watch whether recurring dialysis workflows keep supporting the story.

## Recent News
- 2022-03-09 14:00 EST — [Rockwell Medical Announces Upcoming Poster Presentation at the National Home Infusion Association’s 2022 Annual Conference](https://biopharmsignal.com/news/RMTI/rockwell-medical-announces-upcoming-poster-presentation-at-the-national-home-inf-9a626f17) — Source: Rockwell Medical
- 2022-02-15 13:30 EST — [Rockwell Medical, Inc. to Present at Aegis Virtual Conference](https://biopharmsignal.com/news/RMTI/rockwell-medical-inc-to-present-at-aegis-virtual-conference-5b000457) — Source: Rockwell Medical
- 2022-02-14 21:05 EST — [Rockwell Medical Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RMTI/rockwell-medical-announces-inducement-grant-under-nasdaq-listing-rule-5635-c-4-a2448c66) — Source: Rockwell Medical
- 2022-01-20 14:15 EST — [Rockwell Medical Announces Regulatory Approval of Triferic® Dialysate in South Korea](https://biopharmsignal.com/news/RMTI/rockwell-medical-announces-regulatory-approval-of-triferic-dialysate-in-south-ko-7eb09770) — Source: Rockwell Medical
- 2022-01-13 13:21 EST — [Rockwell Medical Announces Regulatory Approval of Triferic® AVNU in South Korea](https://biopharmsignal.com/news/RMTI/rockwell-medical-announces-regulatory-approval-of-triferic-avnu-in-south-korea-8e9cee85) — Source: Rockwell Medical